2-amino-N-ethyl-1-(5-hydroxy-2-methylphenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide

ID: ALA5204618

PubChem CID: 168296407

Max Phase: Preclinical

Molecular Formula: C20H19N5O2

Molecular Weight: 361.41

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)c1c(N)n(-c2cc(O)ccc2C)c2nc3ccccc3nc12

Standard InChI:  InChI=1S/C20H19N5O2/c1-3-22-20(27)16-17-19(24-14-7-5-4-6-13(14)23-17)25(18(16)21)15-10-12(26)9-8-11(15)2/h4-10,26H,3,21H2,1-2H3,(H,22,27)

Standard InChI Key:  LYDDLRIMQHLRGU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -1.1440    0.2797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9726   -0.5272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1517   -0.6135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1839    0.1404    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4291    0.6924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4291    1.5178    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440    1.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440    2.7562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8589    3.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5739    2.7562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5739    1.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8589    1.5178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8589    0.6924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9918    0.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1847    1.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9769    1.3478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    1.9895    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5739    0.7777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3787   -0.0242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5864   -0.2561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4301   -0.8978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1784   -1.1854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5231   -1.1410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2669   -1.9262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8185   -2.5410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6135   -3.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1693   -1.0047    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
  7 12  2  0
 12 13  1  0
 13  1  2  0
  4 14  1  0
 15 14  1  0
 16 15  2  0
 16 17  1  0
 18 16  1  0
 19 18  2  0
 20 19  1  0
 14 20  2  0
 20 21  1  0
  3 22  1  0
 23  2  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 27 23  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5204618

    ---

Associated Targets(Human)

PKMYT1 Tchem Tyrosine- and threonine-specific cdc2-inhibitory kinase (954 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.41Molecular Weight (Monoisotopic): 361.1539AlogP: 2.92#Rotatable Bonds: 3
Polar Surface Area: 106.06Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 10.38CX Basic pKa: 1.00CX LogP: 3.58CX LogD: 3.58
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -1.12

References

1. Szychowski J, Papp R, Dietrich E, Liu B, Vallée F, Leclaire ME, Fourtounis J, Martino G, Perryman AL, Pau V, Yin SY, Mader P, Roulston A, Truchon JF, Marshall CG, Diallo M, Duffy NM, Stocco R, Godbout C, Bonneau-Fortin A, Kryczka R, Bhaskaran V, Mao D, Orlicky S, Beaulieu P, Turcotte P, Kurinov I, Sicheri F, Mamane Y, Gallant M, Black WC..  (2022)  Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306.,  65  (15.0): [PMID:35880755] [10.1021/acs.jmedchem.2c00552]

Source